Population Pharmacokinetic Modeling of Standard- and High-Dose Rifampicin for Tuberculosis Preventive Therapy in the 2R2 Randomized Controlled Trial

Journal:

Journal of Infectious Diseases

Published:

2026-04-29

DOI:

10.1093/infdis/jiag052

Affiliations:

16

Authors:

14

Go to article

Institutions	Authors	Share
McGill University, Canada	2.666667	0.19
Universitas Padjadjaran, Indonesia	2.000000	0.14
Radboud University Medical Centre (Radboudumc), RU, Netherlands	1.500000	0.11
McGill University Health Centre (MUHC), Canada	1.333333	0.10
University of Calgary (U of C), Canada	1.000000	0.07
The University of Sydney (USYD), Australia	1.000000	0.07
National Lung Hospital, Vietnam	1.000000	0.07
University of Alberta (U of A), Canada	1.000000	0.07
Uppsala University (UU), Sweden	0.500000	0.04
Woolcock Institute of Medical Research (WIMR), Australia	0.500000	0.04
University of Sydney Vietnam Institute, Vietnam	0.500000	0.04
The University of British Columbia (UBC), Canada	0.500000	0.04
BC Centre for Disease Control (BCCDC), PHSA, Canada	0.500000	0.04

Interested in Pharmacology and Pharmaceutical Sciences?